Home » Authors » Nuala Moran

Articles by Nuala Moran

Prolysis Gets $9.9M, Aims For Clinic By End Of 2006

June 1, 2005

Ardana Reports Positive Data In Teverelix LA Phase IIa Trial

June 1, 2005

Animal Testing Ethics Report Reaches No Solid Solution

June 1, 2005

Animal Testing Ethics Report Reaches No Solid Solution

June 1, 2005

Prolysis Gets $9.9M, Aims For Clinic By End Of 2006

June 1, 2005

Ardana Reports Positive Data In Teverelix LA Phase IIa Trial

June 1, 2005

Moving Fast, Astex Cleared For Clinical Trial Of AT 7519

May 25, 2005

ProStrakan Wants £50M IPO In Tough UK Public Market

May 25, 2005

Oxagen Brings In $59.8M; U.S. Firm As Lead Investor

May 25, 2005

Oxagen Brings In $59.8M; U.S. Firm As Lead Investor

May 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...